Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 01, 2017 17:05 ET | Source: NewLink Genetics Corporation

NewLink Genetics Announces Presentation of Two Abstracts at AACR

AMES, Iowa, March 01, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with...
February 28, 2017 08:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics Provides Operational & Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial Results

AMES, Iowa, Feb. 28, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer,...
February 20, 2017 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial Results Conference Call on February 28, 2017

AMES, Iowa, Feb. 20, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), today reported that it will release its fourth quarter and year end 2016 financial results on Tuesday,...
February 13, 2017 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th

AMES, Iowa, Feb. 13, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer,...
November 09, 2016 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Participate in Three Investor Conferences in November

AMES, Iowa, Nov. 09, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer,...
November 01, 2016 08:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2016 Financial Results

AMES, Iowa, Nov. 01, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with...
October 25, 2016 16:05 ET | Source: NewLink Genetics Corporation

NewLink Genetics Shares Its Immuno-Oncology Strategy 2016 Analyst and Investor Day

Two Distinct IDO Pathway Inhibitors in Clinical Development Indoximod, Exclusive to NewLink GeneticsGDC-0919 in Partnership with Genentech, a Member of the Roche Group AMES, Iowa & NEW YORK,...
October 24, 2016 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Host Its Third Quarter 2016 Financial Results Conference Call on November 1, 2016

AMES, Iowa, Oct. 24, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), today reported that it will release its third quarter 2016 financial results on Tuesday, November 1,...
October 20, 2016 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Webcast 2016 Analyst and Investor Day on October 25, 2016

AMES, Iowa, Oct. 20, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will webcast its Analyst and Investor Day being held on Tuesday, October...
October 04, 2016 16:10 ET | Source: NewLink Genetics Corporation

NewLink Genetics Awarded $25 Million Contract from BARDA for Investigational Ebola Zaire Vaccine (V920)

AMES, Iowa, Oct. 04, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), announced today that the Biomedical Advanced Research and Development Authority (BARDA) of the United...